JP2005516923A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516923A5
JP2005516923A5 JP2003552270A JP2003552270A JP2005516923A5 JP 2005516923 A5 JP2005516923 A5 JP 2005516923A5 JP 2003552270 A JP2003552270 A JP 2003552270A JP 2003552270 A JP2003552270 A JP 2003552270A JP 2005516923 A5 JP2005516923 A5 JP 2005516923A5
Authority
JP
Japan
Prior art keywords
preparation
range
pharmaceutical
weight
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003552270A
Other languages
English (en)
Japanese (ja)
Other versions
JP4695838B2 (ja
JP2005516923A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/014104 external-priority patent/WO2003051337A1/de
Publication of JP2005516923A publication Critical patent/JP2005516923A/ja
Publication of JP2005516923A5 publication Critical patent/JP2005516923A5/ja
Application granted granted Critical
Publication of JP4695838B2 publication Critical patent/JP4695838B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003552270A 2001-12-14 2002-12-12 結合型エストロゲン天然混合物を錠剤化するためのプレ調製物 Expired - Fee Related JP4695838B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01129840.3 2001-12-14
EP01129840 2001-12-14
PCT/EP2002/014104 WO2003051337A1 (de) 2001-12-14 2002-12-12 Präformulierung für die tablettierung von natürlichen gemischen konjugierter oestrogene

Publications (3)

Publication Number Publication Date
JP2005516923A JP2005516923A (ja) 2005-06-09
JP2005516923A5 true JP2005516923A5 (enExample) 2006-01-05
JP4695838B2 JP4695838B2 (ja) 2011-06-08

Family

ID=8179550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003552270A Expired - Fee Related JP4695838B2 (ja) 2001-12-14 2002-12-12 結合型エストロゲン天然混合物を錠剤化するためのプレ調製物

Country Status (13)

Country Link
US (2) US8273728B2 (enExample)
EP (1) EP1458363B1 (enExample)
JP (1) JP4695838B2 (enExample)
CN (2) CN100502839C (enExample)
AR (1) AR037642A1 (enExample)
AU (1) AU2002358682B2 (enExample)
BR (1) BR0214954A (enExample)
CA (1) CA2470209A1 (enExample)
ES (1) ES2403218T3 (enExample)
MX (1) MXPA04005767A (enExample)
PL (1) PL205544B1 (enExample)
TW (1) TWI332400B (enExample)
WO (1) WO2003051337A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9586335B2 (en) * 2010-01-27 2017-03-07 Sd3, Llc Blade guard with dust collection
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
US8349819B2 (en) 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CA2768452A1 (en) * 2009-07-16 2011-01-20 Avantor Performance Materials, Inc. Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
EP2787987B1 (de) * 2011-12-08 2016-06-01 Hexal AG Neue pharmazeutische statin-zusammensetzung
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US20210246928A1 (en) * 2020-02-11 2021-08-12 Carl Chasse Fastener having improved wobble control, fastening system including the same, and method of forming the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
US4154820A (en) 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
DE3535536A1 (de) * 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
ATE264110T1 (de) 1996-08-30 2004-04-15 Solvay Pharm Gmbh Prozess zur gewinnung von oestrogenen aus stutenharn
DK0923381T3 (da) 1996-08-30 2004-05-10 Solvay Pharm Gmbh Fremgangsmåde til fremstilling af östrogener ud fra hoppeurin
US6200289B1 (en) 1998-04-10 2001-03-13 Milestone Scientific, Inc. Pressure/force computer controlled drug delivery system and the like
JP2000156938A (ja) 1998-11-19 2000-06-06 Hokuto Denko Kk 電池の充放電試験装置
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens

Similar Documents

Publication Publication Date Title
JP2005516923A5 (enExample)
JP4695838B2 (ja) 結合型エストロゲン天然混合物を錠剤化するためのプレ調製物
CN105813633B (zh) 匹莫苯的改善的药物组合物
HU228772B1 (en) Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
CZ20004201A3 (cs) Farmaceutický prostředek obsahující Levothyroxin natrium a způsob jeho výroby
JPH10501535A (ja) 発泡系及び製剤学的活性物質を含む顆粒状生成物又は錠剤並びにその調整方法
RU96120083A (ru) Гранулированный продукт или таблетка, содержащие шипучую систему и активное фармацевтическое средство, а также способ их получения
JPH09509669A (ja) 発泡系及び製剤学的活性物質を含む顆粒状生成物又は錠剤並びにその調整方法
JPH0774153B2 (ja) ロキソプロフェン・ナトリウム含有製剤
JPH05320045A (ja) 錠剤に直接圧縮可能な医薬粉末組成物を製造するための噴霧乾燥法
KR100740370B1 (ko) 아스코르브산 및 펙틴을 포함하는 조성물
JP4293572B2 (ja) ロキソプロフェン・ナトリウム含有錠剤
JP2987334B2 (ja) 安定なビタミンｂ１２類含有医薬粒子及びこれを用いた安定な固形経口複合医薬製剤
JPS6320409B2 (enExample)
JPH029007B2 (enExample)
WO1999020276A1 (fr) Composition medicamenteuse stable
JP2005502676A (ja) ペクチン及びアスコルビン酸を含む組成物
US5534551A (en) Aminoguanidine spray drying process
EP1592406A2 (en) Lipophilic compositions
CN101385717B (zh) 一种含活性成分索法酮的固体分散物及其制备方法
CS261898B2 (en) Method of homogeneous granulation product making
JPH11510158A (ja) 自由流動性圧縮可能粉末を製造する同時加工方法及びこれから錠剤を製造する方法
WO2001092268A1 (en) Process for drying amoxicillin
SK11098A3 (en) Process for preparing solid dosage forms of very low-dose drugs
JPH0231691B2 (enExample)